Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 462794Generated: October 25, 2026

Acetic Acid → (E)-6-acetoxy-2-(3-cyclohexyl-3-oxoprop-1-enyl)bicyclo[3,3,0]octane

https://huagongshe.com/reaction/462794

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAcetic AcidHCID 176—
ReactantSodium hydrideHCID 24758—
ReactantDimethyl (2-cyclohexyl-2-oxoethyl)phosphonateHCID 13187487—
Reactant6-Acetoxy-2-formylbicyclo[3,3,0]octaneHCID 20397191—
Catalyst18-Crown-6HCID 28557—
SolventDiethyl EtherHCID 3283—
SolventTetrahydrofuranHCID 8028—
Product(E)-6-acetoxy-2-(3-cyclohexyl-3-oxoprop-1-enyl)bicyclo[3,3,0]octaneHCID 20397209—

Reaction Conditions

Temperature0 °C

Reaction Steps

Dimethyl(2-cyclohexyl-2-oxoethyl)phosphonate (3.3 g) was added to a stirred suspension of sodium hydride (0.34 g) and 1,4,7,10,13,16-hexaoxacyclooctadecane (10 mg) in dry tetrahydrofuran (90 ml) in an atmosphere of argon and the mixture was stirred for 12 hours. The mixture was then cooled to 0° C. and treated dropwise with 6-acetoxy-2-formylbicyclo[3,3,0]octane (1.05 g; prepared as described in Reference Example 21 and predominantly in the 2β-configuration). The reaction mixture was allowed to warm to room temperature and then it was stirred for a further period of 24 hours. A solution of glacial acetic acid (400 mg) in diethyl ether (1 ml) was then added and the mixture was concentrated in vacuo. The residue was dissolved in ethyl acetate (10 ml) and the resulting solution was washed with water (10 ml) and then with saturated aqueous sodium chloride solution (10 ml), dried over magnesium sulphate, and concentrated in vacuo. The resulting oil was treated with acetic anhydride (1 ml) and pyridine (4 ml) at 20° C. and left to stand for 12 hours. Concentration at 0.01 mmHg gave an oil, which was subjected to chromatography on a silica gel column, eluting with mixtures of ethyl acetate and hexane (1:6 v/v and then 1:1 v/v), to give (E)- 6-acetoxy-2-(3-cyclohexyl-3-oxoprop-1-enyl)bicyclo[3,3,0]octane (0.84 g), predominantly in the 2β-configuration.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04517202
Source datasetuspto-grants-1985_05
ORD IDord-8420e38d297d4de68e98b6d63c19c103
Source noteuspto-grants-1985_05